Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
The week in pharma: action, reaction and insight – week to August 14, 2026
1+ hour, 21+ min ago (314+ words) Deal-making news last week including Spanish dermatology specialist Almirall entering into a research collaboration with China’s CrystalO Biopharma. Sentynl entered a deal to license lung disease candidate alvelestat from Mereo BioPharma, which could earn the latter nearly half a billion…...
Amgen to establish major research and innovation Centre in Hyderabad's Genome Valley
2+ hour, 26+ min ago (261+ words) Prop News Time US-Iran War & Its Impact on Indian Real Estate De-coding REITs | Understanding Real Estate Investment Trusts Prop Personalities | Raahil Reddy | Fortune Primero | Leadership, Legacy & Innovation in Real Estate Decoding Data Centres & Digital Infrastructure | What are Data Centres & How…...
Peak XV and the art of scaling
2+ hour, 50+ min ago (38+ words) Fortune India This story belongs to the Fortune India Magazine August 2026 issue. SHAILENDRA SINGH still remembers the first time he met Kunal Shah, the newly appointed global head of WhatsApp....
BIOCAPTIVA appoints new chair
4+ hour, 30+ min ago (345+ words) Published by Bdaily Bdaily Business News on 16 Aug 2026 University of Edinburgh spin-out BIOCAPTIVA has appointed experienced life sciences executive Stephane Argivier as chair as it targets its next phase of international growth. Stephane brings 30 years’ experience, including 15 years at board…...
Bristol Myers Squibb: Building a Texas Manufacturing Campus
4+ hour, 49+ min ago (475+ words) Bristol Myers Squibb has confirmed plans to construct a US$2.3bn manufacturing campus in Houston, Texas. The facility will form part of the company's broader US$40bn investment programme across US research, development, technology and domestic manufacturing over five years. The project…...
Aizen Raises Up to $100M Per Target in San Diego Biotech Peptide Deal
5+ hour, 25+ min ago (248+ words) The Clinical Trial Vanguard Aizen Raises Up to $100M Per Target in San Diego Biotech Peptide Deal A seed-stage company that raised $13 million less than two years ago just locked in a deal worth up to $100 million per nominated target, and…...
Skye Bioscience Acquires Redx Pharma, Exits Obesity for Fibrosis Focus
5+ hour, 23+ min ago (217+ words) The Clinical Trial Vanguard Skye Bioscience Acquires Redx Pharma, Exits Obesity for Fibrosis Focus Skye Bioscience is walking away from obesity entirely. The company announced on August 14, 2026, that it has signed a transaction agreement to acquire Redx Pharma Limited and…...
Optegra appoints new UK managing director
5+ hour, 24+ min ago (298+ words) Published by Bdaily Bdaily Business News on 16 Aug 2026 Specialist eye hospital group Optegra Eye Health Care has appointed Ghada Beal as UK managing director as the organisation enters its next phase of growth under owner EssilorLuxottica. Ghada brings more than…...
Citius Pharmaceuticals Reports LYMPHIR Revenue Growth, Explores CAR-T Combination
5+ hour, 25+ min ago (479+ words) The Clinical Trial Vanguard Citius Pharmaceuticals Reports LYMPHIR Revenue Growth, Explores CAR-T Combination An 86% objective response rate in a Phase 1 trial gets attention in any context, but the setting here sharpens the stakes considerably: LYMPHIR (denileukin diftitox-cxdl), approved in August…...
Pathway, which is developing AI models based on what it calls its “Post-Transformer” BDH architecture, raised a $30M seed at a $500M valuation
6+ hour, 20+ min ago (12+ words) Top news and commentary for technology's leaders, from all around the web....